NDC 63323-462-01 - SENSORCAINE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63323-462
- Requested NDC
- 63323-462-01
- Package NDCs from labels
- 63323-462-04, 63323-462-17, 63323-462-01, 63323-462-37, 63323-462-02, 63323-462-31, 63323-462-03, 63323-462-38
- Manufacturer
- Fresenius Kabi USA, LLC
- Effective date
- 2024-10-15
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| SENSORCAINE - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2024-10-15 | HUMAN PRESCRIPTION DRUG LABEL |
| SENSORCAINE MPF - Fresenius Kabi USA, LLC | Fresenius Kabi USA, LLC | 2022-08-17 | HUMAN PRESCRIPTION DRUG LABEL |
| SENSORCAINE MPF - REMEDYREPACK INC. | REMEDYREPACK INC. | 2021-09-20 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63323-462-01 | SENSORCAINEMPF | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 10 | |
| 63323-462-02 | SENSORCAINEMPF | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 10 | |
| 63323-462-04 | SENSORCAINEMPF | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 10 | 10 | |
| 63323-462-17 | SENSORCAINEMPF | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 10 | |
| 63323-462-31 | SENSORCAINEMPF | 5 in 1 BOX | INJECTION, SOLUTION | 5 | 10 | |
| 63323-462-37 | SENSORCAINEMPF | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 10 | |
| 63323-462-03 | SENSORCAINEMPF | 30 mL in 1 VIAL, SINGLE-DOSE | INJECTION, SOLUTION | 30 | 1 | |
| 63323-462-38 | SENSORCAINEMPF | 25 in 1 TRAY | INJECTION, SOLUTION | 25 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63323-462 | SENSORCAINE (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 10 | Current NDC, Legacy NDC, 6 package rows | 20241031_eb6d8fee-def4-4c96-9972-695e8cea8ea8.zip |
| 63323-462 | SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE) INJECTION, SOLUTION SENSORCAINE MPF (BUPIVACAINE HYDROCHLORIDE) INJECTION, SOLUTION [FRESENIUS KABI USA, LLC] | 1 | Current NDC, Legacy NDC, 2 package rows | 20241012_dcf3c0ad-9eb8-4ee7-96df-d0db7ff23175.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63323-462-01 | ML - Milliliter | 63323-462 | 1b92033e-d9a3-49e0-a188-d3d6a6870b65 | 1 | 2021-06-02 |
| 63323-462-03 | ML - Milliliter | 63323-462 | 131a845b-210c-4565-b1ba-3afc2e226992 | 1 | 2024-11-05 |
| 63323-462-04 | ML - Milliliter | 63323-462 | 6222f437-7bba-482c-b18c-90f34f3c4aa0 | 1 | 2020-03-10 |
| 63323-462-17 | ML - Milliliter | 63323-462 | a5c42b08-909e-402c-bcaa-ee1032410b09 | 1 | 2012-07-24 |
| 63323-462-31 | ML - Milliliter | 63323-462 | e635c953-6018-4f14-a690-c954caa7a9ba | 1 | 2012-07-24 |
| 63323-462-37 | ML - Milliliter | 63323-462 | 65d27d34-28f5-4540-8242-8bde8ac0c7ea | 1 | 2012-07-24 |
| 63323-462-38 | ML - Milliliter | 63323-462 | ede728e0-bd7a-47b4-99d7-6df4e8c38ccb | 1 | 2024-11-05 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Hypertonic Saline | SODIUM CHLORIDE | NAVEH PHARMA (1996) LTD | 167c7a9c-1228-4fb2-a89c-d3e148386323 | 2026-07-30 | Warnings | 451W47IQ8X |
| Hypertonic Saline Solution Sodium Chloride | SODIUM CHLORIDE | NAVEH PHARMA (1996) LTD | 750ea4b1-de2b-4299-aaa2-331daf383d0d | 2026-07-30 | Warnings | 451W47IQ8X |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Benco Dental | c5cc87df-df3f-42b8-af84-5f2045d42084 | 2026-07-30 | Warnings, Adverse reactions | 30Q7KI53AK |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Benco Dental | 9419ac39-9b26-4cca-a2d6-167205fede24 | 2026-07-28 | Warnings, Adverse reactions | 30Q7KI53AK |
| IDkit HP ONE | CITRIC ACID ANHYDROUS AND 13C UREA | Meridian Bioscience Israel Ltd | 8baab7a7-5d20-46ad-9c4a-762992ef6b51 | 2026-07-28 | Warnings, Adverse reactions | 2968PHW8QP |
| LIDOCAINE | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Patterson Dental | 6506755f-c9f7-4286-9ba7-ac5d5745f5e4 | 2026-07-28 | Warnings, Adverse reactions | 30Q7KI53AK |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Darby Dental Supply, LLC | 27e8fdfb-e923-4f99-aff7-8b9e50228151 | 2026-07-27 | Warnings, Adverse reactions | 30Q7KI53AK |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Darby Dental Supply, LLC | e5ed4c2a-e320-48cf-a2fd-61d48481c624 | 2026-07-27 | Warnings, Adverse reactions | 30Q7KI53AK |
| Lidocaine | LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | Patterson Dental | f074c0dc-7c3f-46fd-a480-b8337a19fe5c | 2026-07-27 | Warnings, Adverse reactions | 30Q7KI53AK |
| Delflex | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | a98facd6-9daa-4d37-8209-63a0599dbfaa | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care de Mexico, S.A. de C.V. | 9a1220fb-6853-45ae-838c-10d8596e1af7 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | Fresenius Medical Care Renal Therapies Group, LLC | af5cdf1a-19f4-11e2-892e-0800200c9a66 | 2026-07-27 | Warnings, Adverse reactions | 451W47IQ8X |
| PEG 3350 and Electrolytes | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | A-S Medication Solutions | 19daf830-7270-4661-81b1-ded38f867f28 | 2026-07-24 | Warnings, Adverse reactions | 451W47IQ8X |
| Whisidom Saline Solution | SODIUM CHLORIDE 0.9% SALINE SOLUTION | Jiangxi Yudexi Pharmaceutical Co., LTD | 4e4e4169-2a14-3466-e063-6394a90a081b | 2026-07-20 | Warnings | 451W47IQ8X |
| BUPIVACAINE HYDROCHLORIDE | BUPIVACAINE HYDROCHLORIDE | NorthStar RxLLC | ee3b5bbe-4013-4682-b6ee-db86e7788077 | 2026-07-20 | Boxed warning, Warnings, Adverse reactions | 1724880 1724884 1725078 1725082 7TQO7W3VT8 |
| Saline | NASAL | BEST CHOICE (VALU MERCHANDISERS COMPANY) | 71485e82-bf54-4b8b-8dd2-2a0761534520 | 2026-07-17 | Warnings | 451W47IQ8X |
| Sodium Chloride | SODIUM CHLORIDE | LABORATORIOS GRIFOLS SA | eb811d79-fdb8-1f1a-c2ad-1cc4bfc7eadf | 2026-07-15 | Warnings, Adverse reactions | 451W47IQ8X |
| WHWSWB 0.9% SALINE | SODIUM CHLORIDE | Yiwu Huanshu E-commerce Co., Ltd | 5082b773-79b2-2501-e063-6394a90a170f | 2026-07-11 | Warnings | 451W47IQ8X |
| SALINE NASAL | SODIUM CHLORIDE | ALAINA HEALTHCARE PRIVATE LIMITED | ed30a7f9-7132-42da-9bed-63a9b1c80ab2 | 2026-07-07 | Warnings | 451W47IQ8X |
| The Cell Salt Co. Daily Blend 12 in 1 | CALC FLUOR, CALC PHOS, CALC SULPH, FERRUM PHOS, KALI MUR, KALI PHOS, KALI SULPH, MAG PHOS, NAT MUR, NAT PHOS, NAT SULPH, SILICEA | The Cell Salt Company LLC | 55826f59-acf4-7370-e063-6394a90afed7 | 2026-07-01 | Warnings | 451W47IQ8X |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.